Therese Bittermann, MD, MSCE
Dr. Bittermann’s research interests center on the science that underlies liver transplantation practices. She has multiple publications on the impact of organ allocation policies on transplant center behaviors and recipient outcomes. Her work on the lack of standardization in exception point practices in liver transplantation helped to support the creation of the recently implemented National Liver Review Board by the United Network for Organ Sharing. She has also investigated center-level variability in pre- and post-transplant care, as well as pre-operative predictors of morbidity and mortality after liver transplantation. The results of her work have facilitated physician decision-making in the selection of potential candidates for liver transplantation.
Dr. Bittermann’s current research is supported by a K08 Career Development Award from the National Institutes of Health. Using Medicare claims data, she studies practice heterogeneity in immunosuppression management and the association of treatment regimen with key outcomes after transplant, such as severe infections and de novo cancers. Her long-term goal is to develop the evidence base needed to improve quality of life, resource utilization and long-term survival in this unique population. Dr. Bittermann has been awarded financial support from the NIH Loan Repayment Program over two cycles thanks to her research endeavors, and has also received the American Association for the Study of Liver Disease Advanced/Transplant Hepatology Fellowship Award.
Content area specialties: Liver transplantation, immunosuppression, end-stage liver disease, hepatocellular carcinoma, policymaking, practice heterogeneity
Large databases, mixed-methods modeling, pharmacoepidemiology, survival analysis, health services research